comparemela.com
Home
Live Updates
Aquestive Therapeutics Reports Third Quarter 2023 Financial : comparemela.com
Aquestive Therapeutics Reports Third Quarter 2023 Financial
Reiterates commencement of pivotal pharmacokinetic (PK) study for Anaphylmâ„¢ (epinephrine) Sublingual Film expected in fourth quarter 2023 with topline data...
Related Keywords
Daniel Barber ,
Stephanie Carrington ,
Indivior Suboxone ,
Aquestive Therapeutics Inc ,
Nasdaq ,
Development Expense ,
Linkedin ,
Drug Administration ,
Exchange Commission ,
Senior Secured Notes Of The Company ,
Sublingual Film ,
Chief Executive Officer ,
New Drug Application ,
Buccal Film ,
Rectal Gel ,
Riluzole Oral Film ,
Lennox Gastaut Syndrome ,
Attention Deficit Hyperactivity Disorder ,
Senior Secured Notes ,
Note Holders ,
Conference Call ,
Private Securities Litigation Reform Act ,
Quarterly Reports ,
Current Reports ,
Aquestive Therapeutics ,
Consolidated Statements ,
Comprehensive Income ,
Nasdaq Aqst ,
Nc ,
comparemela.com © 2020. All Rights Reserved.